Last reviewed · How we verify
Sulfogal (anethole trithione)
Sulfogal (generic name: anethole trithione) is a anethole trithione drug. It is currently in unknown development.
Sulfogal works by interacting with a specific biological target, although its exact mechanism of action is currently unknown.
Sulfogal, also known as anethole trithione, is a small molecule drug of the anethole trithione class. Its mechanism of action and target are currently unknown. Sulfogal's commercial status and approved indications are also unclear. Further research is needed to determine its efficacy and safety profile. As a result, it is not possible to provide a comprehensive summary of its key safety considerations.
At a glance
| Generic name | anethole trithione |
|---|---|
| Drug class | anethole trithione |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like locks, and Sulfogal is a key that fits into one of those locks. When it binds to the lock, it can affect how the cell works, but we don't know exactly how it does that yet. More research is needed to understand how Sulfogal interacts with cells and what effects it has on the body.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sulfogal CI brief — competitive landscape report
- Sulfogal updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Sulfogal
What is Sulfogal?
How does Sulfogal work?
What is the generic name of Sulfogal?
What drug class is Sulfogal in?
What development phase is Sulfogal in?
Related
- Drug class: All anethole trithione drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing